#HappyThanksgiving from our team to yours! This year has been truly exciting for Sionna, marked by significant milestones that have strengthened our mission of transforming the standard of care for people living with cystic fibrosis (#CF). So far this year, we have successfully expanded our pipeline through a licensing agreement with AbbVie, celebrated a $182 million Series C financing and proudly initiated two Phase 1 clinical trials. Thank you to our team, Board of Directors, investors and the CF community for your unwavering support as we work to normalize #CFTR function. We are #grateful to have you with us on this journey!
Sionna Therapeutics
生物技术
Boston,MA 4,332 位关注者
Dedicated to delivering therapies that could be transformational for people living with cystic fibrosis.
关于我们
We are a life sciences company that is building on over a decade of extensive research on the genetic mutations associated with cystic fibrosis. We are developing first-in-class small molecules that are focused on a unique target with the potential to fully normalize CFTR function for the first time for the vast majority of people living with CF.
- 网站
-
https://www.sionnatx.com/
Sionna Therapeutics的外部链接
- 所属行业
- 生物技术
- 规模
- 11-50 人
- 总部
- Boston,MA
- 类型
- 私人持股
- 创立
- 2019
- 领域
- life sciences、biotechnology、pharmaceuticals、cystic fibrosis、protein function、genetics、genetic mutation、genetic disease、clinical research、clinical study、research、small molecule、molecular engineering、chemistry、patient advocacy、drug development、clinical development、lung、orphan disease和rare disease
地点
-
主要
US,MA,Boston
Sionna Therapeutics员工
动态
-
Our commitment to integrity drives us to execute on our goals with honesty and excellence, always striving to do the right thing. This core value is fundamental to our actions and decisions. By prioritizing integrity, we foster a #culture of shared accountability where every voice is heard and valued. Together, we learn from our experiences, celebrate our successes and focus on continuous improvement. Discover how our “Unwavering Integrity,” along with our other #corevalues, shapes our mission: https://lnkd.in/etdzEAVY
-
Our development programs aim to restore #CFTR function through various pathways, including #NBD1. By targeting this mechanism, we aim to deliver innovative treatment options for individuals with cystic fibrosis (#CF). Learn more about our mission to normalize CFTR function: https://www.sionnatx.com/
-
We are developing a pipeline of #smallmolecules engineered to correct the defects caused by F508del, the most common genetic mutation in cystic fibrosis (#CF). This mutation impairs #CFTR function, impacting the quality of life for individuals with CF. Our mission is to fully normalize CFTR function and improve outcomes for those affected by this condition. Learn more: https://www.sionnatx.com/
-
We’re #hiring an Associate Director of Human Resources to support our growing team.? ? This HR expert will champion Sionna’s values and culture while playing a critical part in managing a wide range of People functions, driving key initiatives in HR compliance, compensation, benefits, performance management and talent acquisition across the organization.? ? ? Interested in learning more? Visit: https://lnkd.in/e-ySVEnt? ? #WereHiring #HiringAlert #JoinOurTeam?
-
We are pleased to announce the appointment of Laurie Stelzer to our Board of Directors.?With more than 25 years of experience in finance and business development across the biopharmaceutical industry, Laurie brings a wealth of expertise that will guide the long-term growth of our company.? ? Her strategic leadership and extensive background will play a key role in our efforts to advance our pipeline of cystic fibrosis (CF) therapies and improve the lives of those impacted by #CF.?? ? Welcome to the Board, Laurie! https://lnkd.in/e3y7KZH8
-
#HiringAlert: We’re looking for a Senior Manager/Associate Director, Accounting & Reporting to join our growing finance and accounting team.?? ? This individual will play a key role in shaping and executing both internal and external financial reporting, developing and overseeing our internal control program and managing our stock plans. They will also be responsible for driving equity reporting, calculating stock-based compensation and supporting the monthly close process.? ? To learn more, visit: https://lnkd.in/eUPVitUb? ? #WereHiring #HiringAlert #JoinOurTeam?
-
Last month we had the honor of welcoming Gunnar Esiason, Executive Vice President, Strategy and Advocacy at the Boomer Esiason Foundation, and a dedicated rare disease advocate living with cystic fibrosis (CF), to our office.? ? Gunnar shared powerful insights from his journey with #CF, discussing the challenges he’s faced and the critical need for advancements in treatment and care. His passion for advocating for patient rights and early-stage drug development deeply resonates with our team, reinforcing our shared goal of improving the lives of those affected by CF.?? ? Thank you, Gunnar, for your inspiring visit. Your commitment to raising awareness for CF fuels important conversations and drives meaningful change.
-
This video from the Cystic Fibrosis Foundation explores the basics of navigating health-related social needs and challenges for individuals impacted by #cysticfibrosis (CF). Watch it here: https://lnkd.in/g7-tyh3X
CF Foundation | Navigating CF: The Basics of Health-Related Social Needs
https://www.youtube.com/
-
Yesterday, our team came together to give back to our community – a tradition we value. We packed baskets of Thanksgiving meals for the Waltham Food Pantry and organized a clothing drive for the Needham Community Council.?? ? Thank you to all who contributed and helped make this event a success. It was inspiring to see everyone join together with such generosity and compassion! HEALTHY WALTHAM ? #SionnaGivesBack #GivingBack?